Cellomics’ Series B+ Financing Round

Sidley represented Cellomics on the financing.Cellomics announced its Series B+ financing. The lead investor is an equity fund of a Hong Kong-listed insurance company. The previous…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now